Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)

Jakub Svoboda, Stefan K. Barta, Daniel J. Landsburg, Sunita Dwivedy Nasta, Wei Hwang, Grace Delp, Brittany Amundsen, Hatcher J. Ballard, James N. Gerson, Elise A. Chong, Mitchell E. Hughes, Steven A. Emanuel, Marco Ruella, Stephen J. Schuster

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)20-21
Number of pages2
Volume136(Supplement 1)
StatePublished - 5 Nov 2020

Cite this